Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule

The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert suspects affected manufacturers will stay on the sidelines rather than back a push to declare the revised schedule unlawful.

Scroll to Top